LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 22

Search options

  1. Article ; Online: Technology and health inequities in diabetes care: How do we widen access to underserved populations and utilize technology to improve outcomes for all?

    Ebekozien, Osagie / Fantasia, Kathryn / Farrokhi, Farnoosh / Sabharwal, Ashutosh / Kerr, David

    Diabetes, obesity & metabolism

    2024  Volume 26 Suppl 1, Page(s) 3–13

    Abstract: Digital health technologies are being utilized increasingly in the modern management of diabetes. These include tools such as continuous glucose monitoring systems, connected blood glucose monitoring devices, hybrid closed-loop systems, smart insulin ... ...

    Abstract Digital health technologies are being utilized increasingly in the modern management of diabetes. These include tools such as continuous glucose monitoring systems, connected blood glucose monitoring devices, hybrid closed-loop systems, smart insulin pens, telehealth, and smartphone applications (apps). Although many of these technologies have a solid evidence base, from the perspective of a person living with diabetes, there remain multiple barriers preventing their optimal use, creating a digital divide. In this article, we describe many of the origins of these barriers and offer recommendations on widening access to digital health technologies for underserved populations living with diabetes to improve their health outcomes.
    MeSH term(s) Humans ; Blood Glucose Self-Monitoring ; Vulnerable Populations ; Blood Glucose ; Diabetes Mellitus/epidemiology ; Diabetes Mellitus/therapy ; Technology ; Health Inequities
    Chemical Substances Blood Glucose
    Language English
    Publishing date 2024-01-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 1454944-x
    ISSN 1463-1326 ; 1462-8902
    ISSN (online) 1463-1326
    ISSN 1462-8902
    DOI 10.1111/dom.15470
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Statistical Comments on "Salivary Iron (Fe) Ion Levels, Serum Markers of Anemia and Caries Activity in Pregnant Women".

    Farrokhi, Mehrdad / Peykanpour, Farnoosh

    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia

    2017  Volume 39, Issue 10, Page(s) 583

    Title translation Comentários estatísticos sobre “Níveis de íon ferro (Fe) salivar, marcadores séricos de anemia, e atividade de cárie em mulheres grávidas”.
    MeSH term(s) Anemia ; Biomarkers ; Female ; Humans ; Iron ; Pregnancy
    Chemical Substances Biomarkers ; Iron (E1UOL152H7)
    Language English
    Publishing date 2017-08-07
    Publishing country Brazil
    Document type Letter ; Comment
    ZDB-ID 2105176-8
    ISSN 1806-9339 ; 0100-7203
    ISSN (online) 1806-9339
    ISSN 0100-7203
    DOI 10.1055/s-0037-1605374
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Effect of surgical intraocular pressure lowering on retinal structures-nerve fibre layer, foveal avascular zone, peripapillary and macular vessel density: 1 year results.

    Farrokhi, Mehrdad / Ebrahimi, Milad / Peykanpour, Farnoosh

    Eye (London, England)

    2019  Volume 34, Issue 9, Page(s) 1710

    MeSH term(s) Humans ; Intraocular Pressure ; Macula Lutea ; Nerve Fibers ; Tonometry, Ocular
    Keywords covid19
    Language English
    Publishing date 2019-11-13
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 91001-6
    ISSN 1476-5454 ; 0950-222X
    ISSN (online) 1476-5454
    ISSN 0950-222X
    DOI 10.1038/s41433-019-0674-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Vascular Endothelial Growth Factor-loaded Bioresorbable Delivery System for Pulp Regeneration.

    Farrokhi, Mehrdad / Peykanpour, Farnoosh

    Journal of endodontics

    2017  Volume 43, Issue 9, Page(s) 1414

    MeSH term(s) Absorbable Implants ; Animals ; Cell Survival/drug effects ; Cells, Cultured ; Dental Papilla/cytology ; Dental Pulp/physiology ; Dental Pulp Cavity ; Drug Delivery Systems ; Humans ; Mice ; Regeneration ; Regenerative Endodontics/methods ; Stem Cells/physiology ; Time Factors ; Tooth Apex/cytology ; Vascular Endothelial Growth Factor A/administration & dosage ; Vascular Endothelial Growth Factor A/adverse effects
    Chemical Substances Vascular Endothelial Growth Factor A
    Language English
    Publishing date 2017-08-18
    Publishing country United States
    Document type Letter
    ZDB-ID 752412-2
    ISSN 1878-3554 ; 0099-2399
    ISSN (online) 1878-3554
    ISSN 0099-2399
    DOI 10.1016/j.joen.2017.05.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Interleukin 17 and 10 in relapsing remitting multiple sclerosis.

    Farrokhi, Mehrdad / Masoudifar, Aria / Peykanpour, Farnoosh

    Journal of the neurological sciences

    2017  Volume 378, Page(s) 63

    MeSH term(s) Egypt ; Humans ; Interleukin-17 ; Interleukins ; Multiple Sclerosis ; Multiple Sclerosis, Relapsing-Remitting
    Chemical Substances Interleukin-17 ; Interleukins
    Language English
    Publishing date 2017-04-26
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 80160-4
    ISSN 1878-5883 ; 0022-510X ; 0374-8642
    ISSN (online) 1878-5883
    ISSN 0022-510X ; 0374-8642
    DOI 10.1016/j.jns.2017.04.044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Statistical Comments on “Salivary Iron (Fe) Ion Levels, Serum Markers of Anemia and Caries Activity in Pregnant Women”

    Farrokhi, Mehrdad / Peykanpour, Farnoosh

    Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics

    2017  Volume 39, Issue 10, Page(s) 583–583

    Language English
    Publishing date 2017-08-07
    Publisher Thieme Revinter Publicações Ltda
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 2105176-8
    ISSN 1806-9339 ; 0100-7203
    ISSN (online) 1806-9339
    ISSN 0100-7203
    DOI 10.1055/s-0037-1605374
    Database Thieme publisher's database

    More links

    Kategorien

  7. Article ; Online: Hypoglycemia in the hospital inpatient setting

    Guillermo E Umpierrez / Dawn Smiley / Farnoosh Farrokhi

    Diabetic Hypoglycemia, Vol 5, Iss 2, Pp 3-

    2012  Volume 8

    Keywords diabetic hypoglycemia ; Diseases of the endocrine glands. Clinical endocrinology ; RC648-665 ; Specialties of internal medicine ; RC581-951 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Internal medicine ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
    Language English
    Publishing date 2012-10-01T00:00:00Z
    Publisher ESP Bioscience
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Etanercept-induced hypoglycemia and improved glycemic control in a patient with type 2 diabetes.

    Farrokhi, Farnoosh / Taylor, Harris C / McBride, Nancy M

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

    2011  Volume 17, Issue 2, Page(s) 306–307

    MeSH term(s) Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Blood Glucose/drug effects ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/drug therapy ; Etanercept ; Female ; Humans ; Hypoglycemia/blood ; Hypoglycemia/drug therapy ; Immunoglobulin G/adverse effects ; Immunoglobulin G/therapeutic use ; Middle Aged ; Receptors, Tumor Necrosis Factor/therapeutic use
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal ; Blood Glucose ; Immunoglobulin G ; Receptors, Tumor Necrosis Factor ; Etanercept (OP401G7OJC)
    Language English
    Publishing date 2011-04-15
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 1473503-9
    ISSN 1934-2403 ; 1530-891X
    ISSN (online) 1934-2403
    ISSN 1530-891X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Idiopathic (primary) achalasia.

    Farrokhi, Farnoosh / Vaezi, Michael F

    Orphanet journal of rare diseases

    2007  Volume 2, Page(s) 38

    Abstract: Idiopathic achalasia is a primary esophageal motor disorder characterized by esophageal aperistalsis and abnormal lower esophageal sphincter (LES) relaxation in response to deglutition. It is a rare disease with an annual incidence of approximately 1/100, ...

    Abstract Idiopathic achalasia is a primary esophageal motor disorder characterized by esophageal aperistalsis and abnormal lower esophageal sphincter (LES) relaxation in response to deglutition. It is a rare disease with an annual incidence of approximately 1/100,000 and a prevalence rate of 1/10,000. The disease can occur at any age, with a similar rate in men and women, but is usually diagnosed between 25 and 60 years. It is characterized predominantly by dysphagia to solids and liquids, bland regurgitation, and chest pain. Weight loss (usually between 5 to 10 kg) is present in most but not in all patients. Heartburn occurs in 27%-42% of achalasia patients. Etiology is unknown. Some familial cases have been reported, but the rarity of familial occurrence does not support the hypothesis that genetic inheritance is a significant etiologic factor. Association of achalasia with viral infections and auto-antibodies against myenteric plexus has been reported, but the causal relationship remains unclear. The diagnosis is based on history of the disease, radiography (barium esophagogram), and esophageal motility testing (esophageal manometry). Endoscopic examination is important to rule out malignancy as the cause of achalasia. Treatment is strictly palliative. Current medical and surgical therapeutic options (pneumatic dilation, surgical myotomy, and pharmacologic agents) aimed at reducing the LES pressure and facilitating esophageal emptying by gravity and hydrostatic pressure of retained food and liquids. Although it cannot be permanently cured, excellent palliation is available in over 90% of patients.
    MeSH term(s) Animals ; Deglutition Disorders/complications ; Deglutition Disorders/diagnosis ; Deglutition Disorders/therapy ; Esophageal Achalasia/complications ; Esophageal Achalasia/diagnosis ; Esophageal Achalasia/therapy ; Esophageal Motility Disorders/complications ; Esophageal Motility Disorders/diagnosis ; Esophageal Motility Disorders/therapy ; Gastroesophageal Reflux/complications ; Gastroesophageal Reflux/diagnosis ; Gastroesophageal Reflux/therapy ; Humans
    Language English
    Publishing date 2007-09-26
    Publishing country England
    Document type Journal Article ; Review
    ISSN 1750-1172
    ISSN (online) 1750-1172
    DOI 10.1186/1750-1172-2-38
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Glycemic control in non-diabetic critically ill patients.

    Farrokhi, Farnoosh / Smiley, Dawn / Umpierrez, Guillermo E

    Best practice & research. Clinical endocrinology & metabolism

    2011  Volume 25, Issue 5, Page(s) 813–824

    Abstract: Hyperglycemia is a common and costly health care problem in hospitalized patients. In hospital hyperglycemia is defined as any glucose value >7.8 mmol/l (140 mg/dl). Hyperglycemia is present in 40% of critically ill patients and in up to 80% of patients ... ...

    Abstract Hyperglycemia is a common and costly health care problem in hospitalized patients. In hospital hyperglycemia is defined as any glucose value >7.8 mmol/l (140 mg/dl). Hyperglycemia is present in 40% of critically ill patients and in up to 80% of patients after cardiac surgery, with ∼ 80% of ICU patients with hyperglycemia having no history of diabetes prior to admission. The risk of hospital complications relates to the severity of hyperglycemia, with a higher risk observed in patients without a history of diabetes compared to those with known diabetes. Improvement in glycemic control reduces hospital complications and mortality; however, the ideal glycemic target has not been determined. A target glucose level between 7.8 and 10.0 mmol/l (140 and 180 mg/dl) is recommended for the majority of ICU patients. This review aims to present updated recommendations for the inpatient management of hyperglycemia in critically ill patients with and without a history of diabetes.
    MeSH term(s) Critical Care/trends ; Critical Illness/therapy ; Humans ; Hyperglycemia/complications ; Hyperglycemia/drug therapy ; Hyperglycemia/etiology ; Hyperglycemia/prevention & control ; Hypoglycemia/complications ; Hypoglycemia/etiology ; Hypoglycemia/prevention & control ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Insulin/adverse effects ; Insulin/therapeutic use
    Chemical Substances Hypoglycemic Agents ; Insulin
    Language English
    Publishing date 2011-09-15
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2052339-7
    ISSN 1878-1594 ; 1532-1908 ; 1521-690X
    ISSN (online) 1878-1594 ; 1532-1908
    ISSN 1521-690X
    DOI 10.1016/j.beem.2011.05.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top